HDAC Inhibitors as Epigenetic Regulators

The results demonstrated that picroliv can inhibit the NF-B activation pathway leading to suppression of the expression of NF-B-regulated proteins and potentiation of apoptosis in tumor cells. == Materials and Methods == == Reagents == A 50-mg/mL solution of picroliv (supplied by Sabinsa Corporation) was prepared in dimethyl sulfoxide, stored as small aliquots FEN1 at -20C, and then diluted as needed in a cell culture medium. NF-B-regulated proteins, including those linked with cell survival (IAP1, Bcl-2, Bcl-xL, survivin, and TRAF2), proliferation (cyclin D1 and COX-2), angiogenesis (VEGF), and invasion (ICAM-1 and MMP-9). Suppression of these proteins, enhanced apoptosis induced by TNF. Overall, our results demonstrate that picroliv inhibits the NF-B activation pathway, which may explain its anti-inflammatory and anticarcinogenic effects. Keywords:Picroliv, NF-B, TNF, Invasion, Angiogenesis == Introduction == Identification of the active components and molecular basis for the action of a traditional medicine is likely to make it more acceptable for use in humans, an approach sometimes referred to as reverse pharmacology. The extracts from roots and rhizomes of the plantPicrorhiza kurroa(commonly called as katuka, kutki, or kutaki), are used to Diatrizoate sodium treat a variety of ailments, including fever, hepatitis, allergies, asthma, and other inflammatory diseases (1,2). One of the major active constituents ofPicrorhiza kurroais picroliv, which consists of the iridoid glycosides Diatrizoate sodium picroside-1 and kutkoside at a ratio 1.0:1.5 (w/w) (Fig. 1A). == Figure 1. == A, structure of picroside-I and kutkoside.B, Picroliv suppresses TNF-induced NF-B activation in a dose-dependent manner. KBM-5 cells (2 106) were incubated with picroliv at different concentrations for 12 h and then treated with TNF (0.1 nM) for 30 min. Nuclear extracts of the cells were prepared and assayed for NF-B activation using EMSA. Cell viability was measured by trypan blue assay.C, Picroliv suppresses TNF-induced NF-B activation in a time-dependent manner. KBM-5 cells (2 106) were incubated with 150 g/mL picroliv for the indicated time periods and then treated with TNF (0.1 nM) for 30 min. Nuclear extracts of the cells were then prepared and assayed for NF-B activation using EMSA.D, Picroliv blocks activation of NF-B induced by TNF, OA, CSC, H2O2, PMA, LPS, and EGF. KBM-5 cells (2 106) were preincubated with 150 g/mL picroliv at 37C for 12 h and then treated with TNF (0.1 nM, 30 min), OA (500 nM, 4 h), CSC (10 g/mL, 1 h), hydrogen peroxide (500 M, 2 h), PMA (25 ng/mL, 1 h), LPS (100 ng/mL, 2 h), and EGF (100 ng/mL, 2 h). Nuclear extracts were prepared and assayed for NF-B activation using EMSA (M, medium). Studies have shown that picroliv exhibits hepatoprotective effects against aflatoxin (3-5), oxytetracycline (6), carbon tetrachloride (7), and alcohol (8); protects against ischemia-reperfusion injury of the liver (9) and kidneys (10); and exhibits anti-inflammatory (11), immunomodulatory (12) and anticarcinogenic (13-16) effects. For instance, studies have shown that oral administration of picroliv suppresses 20-methylcholanthrene–induced sarcoma and 7,12-dimethylbenz[]anthracene (DMBA)-initiated papilloma formation in mice (15) and 1,2-dimethylhydrazine hydrochloride-induced liver tumor formation (16) and N-nitrosodiethylamine-induced hepatocarcinogenesis (13,14) in rats. How picroliv mediates these effects is not fully understood. Studies have also shown that picroliv changes the antioxidant status of Diatrizoate sodium cells (17), downregulates the expression of c-Jun and c-fos (18), and inhibits hypoxia-induced downregulation of insulin-like growth factor-1 and -2 in rats (19). Because pro-oxidant, proinflammatory, immunomodulatory, and carcinogenic effects have been linked with activation of nuclear factor kappaB (NF-B, picroliv may mediate these effects through modulation of the NF-B activation pathway. NF-B is an inducible transcription factor that is activated by various carcinogens, inflammatory stimuli, and growth factors and controls the expression of genes linked with survival, proliferation, invasion, and metastasis of tumors (20). Whether picroliv modulates this pathway is not known. We performed the study described herein to evaluate the effect of picroliv on NF-B pathway. The results demonstrated that picroliv can inhibit the NF-B activation pathway leading to suppression of the expression of NF-B-regulated proteins and potentiation of apoptosis in tumor cells. == Materials and Methods == == Reagents == A 50-mg/mL solution of picroliv (supplied by Sabinsa.